IAG Cargo Sees 22% Increase in Constant Climate Product Volumes Amid Growing Pharmaceutical Demand
/https://aviacionlinecdn.eleco.com.ar/media/2025/03/iag_cargo_iberia.jpg)
IAG Cargo, the cargo division of International Airlines Group (IAG), has reported a 22% increase in the volume of its Constant Climate product compared to 2023. This growth highlights the rising demand for temperature-controlled air transportation within the pharmaceutical industry.
The Constant Climate product, as detailed by IAG Cargo, is specifically designed for the transportation of pharmaceutical products, including vaccines, biotechnology products, diagnostic samples, and other temperature-sensitive materials. This cold chain service has become a critical solution to ensure the safety and effectiveness of pharmaceutical products during transit.
Pharmaceutical Sector Expansion Drives Growth
The global pharmaceutical sector continues to expand, driven by the aging population, growing demand for new treatments, and advances in research and development. Since a large portion of pharmaceutical products require controlled transport to preserve their efficacy, air cargo plays a pivotal role in ensuring that medicines reach patients quickly and in optimal conditions.
Jordan Kohlbeck, Head of the Pharmaceutical Sector at IAG Cargo, stated, “The safe and controlled movement of pharmaceutical products is more important than ever due to increasing global demand, medical advancements, regulatory requirements, and the urgent need for rapid responses during health crises.” He also highlighted IAG Cargo’s commitment to providing world-class temperature control solutions, noting that the company has made significant investments in both its facilities and staff to ensure the precise delivery of these products.
Key Pharmaceutical Export Growth
IAG Cargo noted that a significant portion of its shipments originates from Ireland and India, countries that have seen growth in pharmaceutical exports. In January 2024, Ireland's pharmaceutical exports increased by 48% compared to the same month the previous year, reaching €8.993 billion, representing 48% of the country’s total exports. Meanwhile, India’s pharmaceutical exports grew from $2.13 billion in 2023 to $2.31 billion in 2024, representing about 20% of the global pharmaceutical supply chain.
New Facilities and Expanded Network
The increase in Constant Climate volumes has also been fueled by the opening of IAG Cargo's new Premia facility at its London Heathrow headquarters, which includes a Constant Climate Quality Center (CCQC) for pharmaceutical products. This new facility has doubled the company’s cold chain storage and handling capacity.
Additionally, IAG Cargo has expanded the number of stations approved for transporting temperature-sensitive products, recently adding Cincinnati, Cape Town, and Strasbourg to its global network of approximately 100 stations.
Para comentar, debés estar registradoPor favor, iniciá sesión